Literature DB >> 30165047

microRNA 193a-5p Regulates Levels of Nucleolar- and Spindle-Associated Protein 1 to Suppress Hepatocarcinogenesis.

Sanchari Roy1, Guido J Hooiveld2, Marco Seehawer3, Stefano Caruso4, Florian Heinzmann3, Anne T Schneider5, Anna K Frank6, David Vargas Cardenas5, Roland Sonntag6, Mark Luedde7, Christian Trautwein6, Ilan Stein8, Eli Pikarsky8, Sven Loosen6, Frank Tacke6, Marc Ringelhan9, Seda Kilinc Avsaroglu10, Andrei Goga10, Marie-Annick Buendia11, Mihael Vucur5, Mathias Heikenwalder12, Jessica Zucman-Rossi4, Lars Zender13, Christoph Roderburg6, Tom Luedde14.   

Abstract

BACKGROUND & AIMS: We performed an integrated analysis to identify microRNAs (miRNAs) and messenger RNAs (mRNAs) with altered expression in liver tumors from 3 mouse models of hepatocellular carcinoma (HCC) and human tumor tissues.
METHODS: We analyzed miRNA and mRNA expression profiles of liver tissues from mice with diethylnitrosamine-induced hepatocarcinogenesis, conditional expression of lymphotoxin alpha and lymphotoxin beta, or inducible expression of a Myc transgene (Tet-O-Myc mice), as well as male C57BL/6 mice (controls). miRNA mimics were expressed and miRNAs and mRNAs were knocked down in human (Huh7, Hep3B, JHH2) hepatoma cell lines; cells were analyzed for viability, proliferation, apoptosis, migration, and invasion. Cells were grown as xenograft tumors in nude mice and analyzed. We combined in silico target gene prediction with mRNA profiles from all 3 mouse models. We quantified miRNA levels in 146 fresh-frozen tissues from patients (125 HCCs, 17 matched nontumor tissues, and 4 liver samples from patients without cancer) and published human data sets and tested correlations with patient survival times using Kaplan-Meier curves and the log-rank test. Levels of NUSAP1 mRNA were quantified in 237 HCCs and 5 nontumor liver samples using the TaqMan assay.
RESULTS: Levels of the miRNA 193a-5p (MIR193A-5p) were reduced in liver tumors from all 3 mouse tumor models and in human HCC samples, compared with nontumor liver tissues. Expression of a MIR193A-5p mimic in hepatoma cells reduced proliferation, survival, migration, and invasion and their growth as xenograft tumors in nude mice. We found nucleolar and spindle-associated protein 1 (NUSAP1) to be a target of MIR193A-5p; HCC cells and tissues with low levels of MIR193A-5p had increased expression of NUSAP1. Increased levels of NUSAP1 in HCC samples correlated with shorter survival times of patients. Knockdown of NUSAP1 in Huh7 cells reduced proliferation, survival, migration, and growth as xenograft tumors in nude mice. Hydrodynamic tail-vein injections of a small hairpin RNA against NUSAP1 reduced growth of Akt1-Myc-induced tumors in mice.
CONCLUSIONS: MIR193A-5p appears to prevent liver tumorigenesis by reducing levels of NUSAP1. Levels of MIR193A-5p are reduced in mouse and human HCC cells and tissues, leading to increased levels of NUSAP1, associated with shorter survival times of patients. Integrated analyses of miRNAs and mRNAs in tumors from mouse models can lead to identification of therapeutic targets in humans. The currently reported miRNA and mRNA profiling data have been submitted to the Gene Expression Omnibus (super-series accession number GSE102418).
Copyright © 2018 AGA Institute. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Gene Regulation; Liver Cancer; Systems Biology; Translation

Mesh:

Substances:

Year:  2018        PMID: 30165047      PMCID: PMC6279541          DOI: 10.1053/j.gastro.2018.08.032

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  44 in total

Review 1.  Lost in translation: animal models and clinical trials in cancer treatment.

Authors:  Isabella Wy Mak; Nathan Evaniew; Michelle Ghert
Journal:  Am J Transl Res       Date:  2014-01-15       Impact factor: 4.060

2.  Chronic lymphocytic inflammation specifies the organ tropism of prions.

Authors:  Mathias Heikenwalder; Nicolas Zeller; Harald Seeger; Marco Prinz; Peter-Christian Klöhn; Petra Schwarz; Nancy H Ruddle; Charles Weissmann; Adriano Aguzzi
Journal:  Science       Date:  2005-01-20       Impact factor: 47.728

3.  RIPK1 Suppresses a TRAF2-Dependent Pathway to Liver Cancer.

Authors:  Anne T Schneider; Jérémie Gautheron; Maria Feoktistova; Christoph Roderburg; Sven H Loosen; Sanchari Roy; Fabian Benz; Peter Schemmer; Markus W Büchler; Ueli Nachbur; Ulf P Neumann; Rene Tolba; Mark Luedde; Jessica Zucman-Rossi; Diana Panayotova-Dimitrova; Martin Leverkus; Christian Preisinger; Frank Tacke; Christian Trautwein; Thomas Longerich; Mihael Vucur; Tom Luedde
Journal:  Cancer Cell       Date:  2016-12-22       Impact factor: 31.743

4.  Cell-Cycle-Targeting MicroRNAs as Therapeutic Tools against Refractory Cancers.

Authors:  Per Hydbring; Yinan Wang; Anne Fassl; Xiaoting Li; Veronica Matia; Tobias Otto; Yoon Jong Choi; Katharine E Sweeney; Jan M Suski; Hao Yin; Roman L Bogorad; Shom Goel; Haluk Yuzugullu; Kevin J Kauffman; Junghoon Yang; Chong Jin; Yingxiang Li; Davide Floris; Richard Swanson; Kimmie Ng; Ewa Sicinska; Lars Anders; Jean J Zhao; Kornelia Polyak; Daniel G Anderson; Cheng Li; Piotr Sicinski
Journal:  Cancer Cell       Date:  2017-04-10       Impact factor: 31.743

5.  The role of tyrosine kinase inhibitors in hepatocellular carcinoma.

Authors:  Sunnie Kim; Ghassan K Abou-Alfa
Journal:  Clin Adv Hematol Oncol       Date:  2014-01

6.  A hepatocellular carcinoma 5-gene score associated with survival of patients after liver resection.

Authors:  Jean-Charles Nault; Aurélien De Reyniès; Augusto Villanueva; Julien Calderaro; Sandra Rebouissou; Gabrielle Couchy; Thomas Decaens; Dominique Franco; Sandrine Imbeaud; Francis Rousseau; Daniel Azoulay; Jean Saric; Jean-Frédéric Blanc; Charles Balabaud; Paulette Bioulac-Sage; Alexis Laurent; Pierre Laurent-Puig; Josep M Llovet; Jessica Zucman-Rossi
Journal:  Gastroenterology       Date:  2013-04-06       Impact factor: 22.682

7.  A lymphotoxin-driven pathway to hepatocellular carcinoma.

Authors:  Johannes Haybaeck; Nicolas Zeller; Monika Julia Wolf; Achim Weber; Ulrich Wagner; Michael Odo Kurrer; Juliane Bremer; Giandomenica Iezzi; Rolf Graf; Pierre-Alain Clavien; Robert Thimme; Hubert Blum; Sergei A Nedospasov; Kurt Zatloukal; Muhammad Ramzan; Sandra Ciesek; Thomas Pietschmann; Patrice N Marche; Michael Karin; Manfred Kopf; Jeffrey L Browning; Adriano Aguzzi; Mathias Heikenwalder
Journal:  Cancer Cell       Date:  2009-10-06       Impact factor: 31.743

8.  Mouse models of hepatocarcinogenesis: what can we learn for the prevention of human hepatocellular carcinoma?

Authors:  Mihael Vucur; Christoph Roderburg; Kira Bettermann; Frank Tacke; Mathias Heikenwalder; Christian Trautwein; Tom Luedde
Journal:  Oncotarget       Date:  2010-09

9.  Critical role of Myc activation in mouse hepatocarcinogenesis induced by the activation of AKT and RAS pathways.

Authors:  B Xin; M Yamamoto; K Fujii; T Ooshio; X Chen; Y Okada; K Watanabe; N Miyokawa; H Furukawa; Y Nishikawa
Journal:  Oncogene       Date:  2017-05-08       Impact factor: 9.867

10.  MicroRNA-193a inhibits breast cancer proliferation and metastasis by downregulating WT1.

Authors:  FeiYan Xie; Sumayyah Hosany; Shen Zhong; Yang Jiang; Fen Zhang; LiLi Lin; XiaoBo Wang; ShenMeng Gao; XiaoQu Hu
Journal:  PLoS One       Date:  2017-10-10       Impact factor: 3.240

View more
  41 in total

Review 1.  Dissecting the mechanisms of cell division.

Authors:  Joseph Y Ong; Jorge Z Torres
Journal:  J Biol Chem       Date:  2019-06-07       Impact factor: 5.157

2.  Knockdown of NUSAP1 inhibits cell proliferation and invasion through downregulation of TOP2A in human glioblastoma.

Authors:  Yaotian Hu; Zhiyi Xue; Chen Qiu; Zichao Feng; Qichao Qi; Jiwei Wang; Wenxing Jin; Zhaoyang Zhong; Xiaofei Liu; Wenjie Li; Qing Zhang; Bin Huang; Anjing Chen; Jian Wang; Ning Yang; Wenjing Zhou
Journal:  Cell Cycle       Date:  2022-05-13       Impact factor: 5.173

3.  Identification and clinical validation of NUSAP1 as a novel prognostic biomarker in ovarian cancer.

Authors:  Rui Gou; Mingjun Zheng; Yuexin Hu; Lingling Gao; Shuang Wang; Ouxuan Liu; Xiao Li; Liancheng Zhu; Juanjuan Liu; Bei Lin
Journal:  BMC Cancer       Date:  2022-06-23       Impact factor: 4.638

4.  KRT6A expedites bladder cancer progression, regulated by miR-31-5p.

Authors:  Yuan Chen; Shiben Ji; Jianxin Ying; Yongchang Sun; Jun Liu; Guohong Yin
Journal:  Cell Cycle       Date:  2022-03-20       Impact factor: 5.173

5.  S100A6/miR193a regulates the proliferation, invasion, migration and angiogenesis of lung cancer cells through the P53 acetylation.

Authors:  Peng Li; Xiaodong Lv; Zhiqiang Zhang; Shanshan Xie
Journal:  Am J Transl Res       Date:  2019-08-15       Impact factor: 4.060

6.  [Musashi-1 positively regulates growth and proliferation of hepatoma cells in vitro].

Authors:  Jie Li; Kun Yan; Yi Yang; Hua Li; Zhidong Wang; Xin Xu
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2019-12-30

7.  Up-regulation of the expressions of MiR-149-5p and MiR-99a-3p in exosome inhibits the progress of pituitary adenomas.

Authors:  Peng Zhao; Jianhua Cheng; Bin Li; Ding Nie; Chuzhong Li; Songbai Gui; Hongyun Wang; Yazhuo Zhang
Journal:  Cell Biol Toxicol       Date:  2021-01-05       Impact factor: 6.691

8.  Serum levels of circulating microRNA-107 are elevated in patients with early-stage HCC.

Authors:  Sven H Loosen; Mirco Castoldi; Markus S Jördens; Sanchary Roy; Mihael Vucur; Jennis Kandler; Linda Hammerich; Raphael Mohr; Frank Tacke; Tom F Ulmer; Ulf P Neumann; Tom Luedde; Christoph Roderburg
Journal:  PLoS One       Date:  2021-03-12       Impact factor: 3.240

9.  NUSAP1 Accelerates Osteosarcoma Cell Proliferation and Cell Cycle Progression via Upregulating CDC20 and Cyclin A2.

Authors:  Haoran Wang; Zixiang Liu; Peng Wu; Hanqing Wang; Weiwei Ren
Journal:  Onco Targets Ther       Date:  2021-05-25       Impact factor: 4.147

10.  Integrated bioinformatics analysis revealed the regulation of angiogenesis by tumor cells in hepatocellular carcinoma.

Authors:  Meisi Huo; Kangkang Yu; Yahui Zheng; Lu Liu; Hao Zhao; Xiaoqi Li; Chong Huang; Jubo Zhang
Journal:  Biosci Rep       Date:  2021-07-30       Impact factor: 3.840

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.